A new class of antiplatelet therapy drug pending U.S. Food and Drug Administration (FDA) clearance may offer ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 15, 2010 – The U.S. Food and Drug Administration (FDA) granted 510(k) market approval for the Medivance ...
September 15, 2010 – A study evaluating the level of platelet aggregation achieved after switching from ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
September 15, 2010 – The U.S. Food and Drug Administration (FDA) has extended the time to complete its review of ...
September 14, 2010 – Transcatheter valves, drug-eluting balloons and the latest stent comparison trial data are ...
September 8, 2010 – The increased effectiveness of ticagrelor (Brilinta) in overcoming high platelet reactivity as ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
Coronary chronic total occlusions (CTOs) are found in about one-third of patients who undergo angiography.(1) ...
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major risk factor for developing ...
August 30, 2010 - Even though cardiac rehabilitation, a medically supervised program of services, can ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
August 25, 2010 – Alleging infringement of a patent for its transcatheter cardiac septal occluder devices, AGA ...
August 25, 2010 – There will be special tracks available for nurses and technologists and for the transcatheter ...
August 19, 2010 – The Intersocietal Accreditation Commission (IAC) this week announced the launch of its new ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
August 19, 2010 – The U.S. Food and Drug Administration (FDA) said last week Boston Scientific has resolved all ...
August 18, 2010 - A new portable system which cools the brain via the nasal cavity may improve survival following ...
August 12, 2010 – A 52-year-old male heart failure patient in Krakow, Poland, became the first human to receive ...
September 15, 2010